Listed

BioCardia, Inc.: Form 10-Q for the period ended Sep 30, 2016

Filed with the SEC on Oct 17, 2016 and accepted by EDGAR at Oct 17, 2016, 17:08 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Operating income3 months2016-07-01 to 2016-09-30$5.1mus-gaap:OperatingIncomeLoss
Operating income9 months2016-01-01 to 2016-09-30$5.3mus-gaap:OperatingIncomeLoss
Income tax3 months2016-07-01 to 2016-09-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax9 months2016-01-01 to 2016-09-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-07-01 to 2016-09-30$5.1mus-gaap:NetIncomeLoss
Net income9 months2016-01-01 to 2016-09-30$5.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-07-01 to 2016-09-30$0.02us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2016-01-01 to 2016-09-30$0.02us-gaap:EarningsPerShareBasicAndDiluted
Diluted shares (weighted)3 months2016-07-01 to 2016-09-30230,537,706 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2016-01-01 to 2016-09-30230,375,258 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Cash and equivalentsAt period end2016-09-30$19.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Total assetsAt period end2016-09-30$19.5mus-gaap:Assets
Total liabilitiesAt period end2016-09-30$330.0kus-gaap:Liabilities
Shareholders' equityAt period end2016-09-30$19.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001136261-16-000628. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.